Literature DB >> 15657605

Genetic and clinical characteristics of maturity-onset diabetes of the young in Chinese patients.

Jian Yu Xu1, Qing Hong Dan, Vivian Chan, Nelson M S Wat, Sidney Tam, Sau Cheung Tiu, Ka Fai Lee, Shing Chung Siu, Man Wo Tsang, Lai Ming Fung, Kin Wah Chan, Karen S L Lam.   

Abstract

In Caucasians, maturity-onset diabetes of the young (MODY) is mostly caused by mutations in the hepatocyte nuclear factor (HNF)-1alpha (MODY3) and glucokinase (MODY2) genes. Most Japanese MODY patients, however, are not linked to known MODY genes. In this study, we examined the genetic and clinical characteristics of Chinese subjects with MODY. The study included 146 unrelated families fulfilling the minimum criteria for MODY: two consecutive generations of type II diabetes with at least one member diagnosed under the age of 25. We screened for mutations in the HNF-4alpha (MODY1), MODY2 and MODY3 genes by direct sequencing. Antibody to glutamic acid decarboxylase (GAD-Ab) was measured in subjects with MODY of unknown cause (MODYX). Insulin resistance index and other clinical data were compared in sex-, age- and duration-matched MODY3 and MODYX patients. In all, 13 families had MODY3 mutations and two had MODY2 mutations. No MODY1 mutation was found. Four of the 12 different MODY3 mutations were newly identified novel mutations (Q243E, A311D, P379R and P488fsdelC). In subjects with MODYX, 3% were GAD-Ab positive and 60% were overweight. Compared to MODY3 patients, MODYX patients had higher body mass index (P<0.02), higher insulin resistance index (P=0.001) and triglyceride level (P<0.02), lower HDL level (P=0.001) and more hypertension (P<0.05), but no significant difference in the prevalence of diabetic complications. In conclusion, MODY3 and MODY2 account for only 9 and 1%, respectively, of Chinese MODY. A majority of Chinese MODY patients are due to defects in unknown genes and appear to be characterized by insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15657605     DOI: 10.1038/sj.ejhg.5201347

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  33 in total

1.  Mutations in KCNJ11 are associated with the development of autosomal dominant, early-onset type 2 diabetes.

Authors:  Limei Liu; Kazuaki Nagashima; Takao Yasuda; Yanjun Liu; Hai-Rong Hu; Guang He; Bo Feng; Mingming Zhao; Langen Zhuang; Taishan Zheng; Theodore C Friedman; Kunsan Xiang
Journal:  Diabetologia       Date:  2013-09-10       Impact factor: 10.122

Review 2.  When is it MODY? Challenges in the Interpretation of Sequence Variants in MODY Genes.

Authors:  Sara Althari; Anna L Gloyn
Journal:  Rev Diabet Stud       Date:  2016-02-10

3.  Identification of Maturity-Onset Diabetes of the Young Caused by Mutation in FOXM1 via Whole-Exome Sequencing in Northern China.

Authors:  Liang Zhong; Zengyi Zhao; Qingshan Hu; Yang Li; Weili Zhao; Chuang Li; Yunqiang Xu; Ruijuan Rong; Jing Zhang; Zifeng Zhang; Nan Li; Zanchao Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-09       Impact factor: 5.555

4.  Insight into the biochemical characteristics of a novel glucokinase gene mutation.

Authors:  Yunfeng Shen; Mengyin Cai; Hua Liang; Hongwei Wang; Jianping Weng
Journal:  Hum Genet       Date:  2010-11-23       Impact factor: 4.132

5.  Clinically-Defined Maturity Onset Diabetes of the Young in Omanis: Absence of the common Caucasian gene mutations.

Authors:  Nicholas Jy Woodhouse; Omayma T Elshafie; Ali S Al-Mamari; Nagi Hs Mohammed; Fatma Al-Riyami; Sandy Raeburn
Journal:  Sultan Qaboos Univ Med J       Date:  2010-04-17

6.  Mutations in HNF1A Gene are not a Common Cause of Familial Young-Onset Diabetes in Iran.

Authors:  Meysam Moghbeli; Bahram Naghibzadeh; Martha Ghahraman; Sedigheh Fatemi; Morteza Taghavi; Rahim Vakili; Mohammad Reza Abbaszadegan
Journal:  Indian J Clin Biochem       Date:  2017-04-13

Review 7.  Undiagnosed MODY: Time for Action.

Authors:  Jeffrey W Kleinberger; Toni I Pollin
Journal:  Curr Diab Rep       Date:  2015-12       Impact factor: 4.810

8.  Clinical features and treatment of maturity onset diabetes of the young (MODY).

Authors:  Daphne Sl Gardner; E Shyong Tai
Journal:  Diabetes Metab Syndr Obes       Date:  2012-05-01       Impact factor: 3.168

9.  Intracellular serotonin modulates insulin secretion from pancreatic beta-cells by protein serotonylation.

Authors:  Nils Paulmann; Maik Grohmann; Jörg-Peter Voigt; Bettina Bert; Jakob Vowinckel; Michael Bader; Masa Skelin; Marko Jevsek; Heidrun Fink; Marjan Rupnik; Diego J Walther
Journal:  PLoS Biol       Date:  2009-10-27       Impact factor: 8.029

10.  Traditional clinical criteria outperform high-sensitivity C-reactive protein for the screening of hepatic nuclear factor 1 alpha maturity-onset diabetes of the young among young Asians with diabetes.

Authors:  Suresh Rama Chandran; Jaydutt Bhalshankar; Rashida Farhad Vasanwala; Yi Zhao; Katharine R Owen; Daphne Su-Lyn Gardner
Journal:  Ther Adv Endocrinol Metab       Date:  2018-05-22       Impact factor: 3.565

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.